Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type B intra-trigonal injections for idiopathic detrusor overactivity
2005-004716-75Phase 4Completed
- Sponsor
- Swansea Bay University Health Board
- Start
- Dec 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type b in idiopathic detrusor overactivity (IDO) (2 arms), sponsored by Swansea Bay University Health Board. Primary endpoint: Reduction of incontinence episodes. Started Dec 2005; status: completed.
02
Drugs
botulinum toxin type b
03
Conditions
idiopathic detrusor overactivity (IDO)
Beyond the preview
Go deeper on 2005-004716-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004716-75.